ECO Animal Health Group plc (LWA.F)

1.2700 +0.0100 (+0.79%) As of 03:29PM CEST. Market open.

ECO Animal Health Group plc

The Grange
100 High Street
London N14 6BN
United Kingdom
44 208 447 8899
https://www.ecoanimalhealthgroupplc.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 234

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. David Charles Hallas	CEO & Director	571.96k	N/A	1964
Mr. Christopher Wilks ACA, BSc, F.C.A.	CFO, Finance Director, Secretary & Director	386.74k	N/A	1964

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.

Corporate Governance

ECO Animal Health Group plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.